Cargando...
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
There are currently seven approved immune checkpoint inhibitors (ICIs) for the treatment of various cancers. These drugs are associated with profound, durable responses in a subset of patients with advanced cancers. Unfortunately, in addition to individuals whose tumors show resistance, there is a m...
Gardado en:
| Publicado en: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011624/ https://ncbi.nlm.nih.gov/pubmed/32043794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0636 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|